Hyperthermia Cancer Treatment Market Size, Share, Forecast Report 2021-2030
The global Hyperthermia Cancer Treatment market gathered revenue around USD156 Million in 2020 and market is set to grow USD 265 Million by the end of 2030. The global Hyperthermia Cancer Treatment market is estimated to expand at a modest CAGR of 7% during the prediction period2021 to 2030.
Hyperthermia, (also called thermal therapy or thermotherapy) is a type of cancer treatment, in which body tissue is exposed to high temperatures to damage or kill cancer cells. The hyperthermia treatment is a non-invasive method of increasing tumor temperature to stimulate blood flow, increase oxygenation, and render tumor cells more sensitive to radiation. By adding hyperthermia to radiation therapy, radiation oncologists can increase tumor control, while minimizing damage to healthy tissues.
North America dominated the global hyperthermia cancer treatment market in 2019. The trend is anticipated to continue during the forecast period, owing to increase in incidence of different types of cancer and rise in diagnosis rate in the region.
This research report purposes at stressing the most lucrative growth prospects.The aim of the research report is to provide an inclusive valuation of the Hyperthermia Cancer Treatment market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Hyperthermia Cancer Treatment market reportaids in comprehendingmarket structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
COVID-19 Impact Assessment on Market Landscape
The report comprises the scrutiny of COVID-19 lock-downimpact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilaracross various industry verticals. The research reportofferspresent short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lastingtactics for recovery and by region.
Hyperthermia Cancer Treatment market report empower readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplish sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share.Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Significant Market Participants Operational in the Hyperthermia Cancer Treatment Market are:
The global hyperthermia cancer treatment market include Pyrexar Medical, Celsius42 GmbH, Hydrosun GmbH, Oncotherm Kft, Andromedic S.r.l., Yamamoto Vinita Co., Ltd., Chongqing Haifu Medical Technology Co., Ltd., innoMedicus Ltd., Gamida, and RanD.
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects includingproduct type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2030 and covers subsequent region in its scope:
Global Hyperthermia Cancer Treatment Market: Segmentation
- Hyperthermia Cancer Treatment Market, by Device Type
- Infrared Hyperthermia Devices
- Ultrasound Hyperthermia Devices
- Microwave Hyperthermia Devices
- Hyperthermia Cancer Treatment Market, by Treatment Method
- External & Interstitial
- Intraluminal or Endocavitary Methods
- Continuous Hyperthermic Peritoneal Perfusion (CHPP)
- Deep Tissue & Regional Perfusion
- Hyperthermia Cancer Treatment Market, by Application
- Breast Cancer
- Liver Cancer
- Soft Tissue Sarcoma
- Head & Neck Tumors
- Prostate Cancer
- Hyperthermia Cancer Treatment Market, by End User
- Hospitals & Specialty Clinics
- Ambulatory Surgical Centers
By Regional Outlook
- United States
- United Kingdom
- Rest of EU
- Southeast Asia
- Rest of APAC
Central & South America
- Rest of Central & South America
Middle East and Africa
- North Africa
- South Africa